Image-based grading was more accurate than standard classification in diagnosing retinopathy of prematurity, according to a study presented at the American Ophthalmological Society meeting in Colorado Springs, Colorado.The identification of plus diseas…
Author: Healio ophthalmology
Approaching the macula from the premium cataract surgeon perspective
Premium cataract surgeons face the daily decision of whether to offer cataract surgery patients the option of multifocal IOL or other advanced IOL technology, which could contribute to current and/or future potential undesirable visual aberrations post…
Retina specialists explore anti-VEGF treatments for diabetic eye disease
As the rising prevalence of diabetes drives demand for care across medical specialties, ophthalmologists are increasingly focused on the causes, prevention and treatment of diabetic eye disease.Overall, 4.2 million adults have diabetic retinopathy and …
VIDEO: Nd:YAG capsulotomy improves vision quality in patients with posterior capsular opacification
At Kiawah Eye, Jake C. McMillin, MD, shares results on a study evaluating intraocular light scatter before and after Nd:YAG capsulotomy.
Parion Sciences initiates phase 2 trial of P-321 ophthalmic solution for dry eye disease
Patient enrollment is underway for a phase 2 clinical trial of P-321 ophthalmic solution for the treatment of dry eye disease, according to a press release from Parion Sciences.The study, P-321-202, will assess the impact of the ophthalmic solution on …
Iontophoretic EGP-437 shows positive early results in treatment of postop ocular inflammation, pain
Iontophoretic EGP-437 showed positive early results in a phase 1b/2a trial evaluating the treatment of ocular inflammation and pain after cataract surgery, EyeGate Pharmaceuticals announced in a press release.The trial included 40 patients who underwen…
VIDEO: Management, treatment options for small pupils
At Kiawah Eye, John A. Hovanesian, MD, FACS, discusses approaches on managing and treating patients with small pupils.
FDA clears Topcon 3-D OCT-1 Maestro system
The FDA has cleared the 3-D OCT-1 Maestro system in the U.S., Topcon Medical Systems announced in a press release. The Maestro system combines a high-resolution color nonmydriatic retinal camera with SD-OCT technology and is equipped with PinPoint regi…
Physician responsibilities for suspected Medicare overpayments
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.Have you ever heard someone in your office say, “I think Medicare may not have paid these claims correctly?” After that statement, did the relevant documents get buried in a pile on a desk — never to be reviewed again? Be careful. Earlier this year, CMS issued a final rule governing the responsibility of providers to report and (Read more...)
Publication Exclusive — Office-based cataract surgery: Pros and cons of a controversial idea
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.The concept of in-office cataract surgery has g…
Certain diabetic retinopathy stages associated with higher levels of depression
The association between depressive symptoms, diabetes and diabetic retinopathy is likely to be bidirectional, with diabetes impairment complicating depression and vice versa, according to a study in JAMA Ophthalmology.The cross-sectional study included…
Presence of MGD has minimal effect on ocular surface in medically treated glaucoma
No additional effect on ocular surface parameters was seen in patients with medically treated glaucoma with or without meibomian gland dysfunction, according to a study.The cross-sectional study included 70 patients with glaucoma on long-term (longer than 1 year) topical hypotensive medications. Meibomian gland dysfunction (MGD) is “frequently encountered” in these patients, according to the researchers, with mild to moderate disease detected in 47 of the 70 patients and minimal signs detected in nine.
VIDEO: Speaker talks about management of DME
At Kiawah Eye, W. Lloyd Clark, MD, gives an update on the management of diabetic macular edema.
VIDEO: Speaker gives update on OCT angiography
At Retina 2016, Carmen A. Puliafito, MD, MBA, gives an update on OCT angiography.
VIDEO: Speaker talks about toric alignment for astigmatism correction
At Hawaiian Eye, Mark Packer, MD, discusses the advantages of posterior chamber presbyopia-correcting IOL, which include improvement in visual acuity and reduction in astigmatism.
FDA approves CyPass micro-stent system for use with cataract surgery
The FDA has approved the CyPass micro-stent system for use in combination with cataract surgery to reduce IOP in adult patients with mild to moderate primary open angle glaucoma, according to a news release from the agency’s Center for Devices and Radiological Health. The CyPass micro-stent system model 241-S (Alcon, a division of Novartis) includes the CyPass micro-stent, a loading device and a stent delivery tool. The micro-stent is placed in the angle of the eye with the distal end residing in the supraciliary space to allow outflow of fluid (Read more...)
Remembering the pioneering work and life of George O. Waring III
George Oral Waring III, MD, FACS, FRCOphth, pioneering refractive surgeon and life enthusiast, died in January 2015 at the age of 73. His contribution to ophthalmology and particularly refractive surgery was only paralleled by his dedication to scienti…
Publication Exclusive — Unsung heroes of dry eye care: Technicians make or break a dry eye clinic
The other day I was hanging around “Sky Bar,” the tech station at SkyVision. Do you have kids? When I am quietly standing there, I am kind of like the parent driving the school carpool: After a short while you become one with the furniture, and the kids talk around you as if you were not even there. My technician teammates were chatting about dry eye patients at the time. This is not all that unusual, in that at least one-third of our patients are active dry eye patients. You (Read more...)
VIDEO: Double pass retinal imaging as a supplementary tool for measuring DED
At Kiawah Eye, Ashley Brundrett, MD, presents results from a study evaluating the use of double pass retinal imaging to analyze visual acuity and tear film instability in dry eye disease.
Xiidra first FDA-approved drug for signs and symptoms of dry eye disease
The FDA approved Xiidra for the treatment of signs and symptoms of dry eye disease in adult patients on July 11. Manufactured by Shire, Xiidra (lifitegrast ophthalmic solution 5%) is the first prescription eye drop medication in a new class of drugs, a lymphocyte function-associated antigen 1 antagonist, to be approved by the FDA for dry eye disease, according to an FDA press release. The drug’s safety and efficacy were assessed in more than 2,500 patients in four separate, randomized controlled studies. The results of the studies found that patients (Read more...)